Your browser doesn't support javascript.
loading
Solid-phase microextraction coupled to gas chromatography-mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues.
Bianchi, Federica; Riboni, Nicolò; Carbognani, Paolo; Gnetti, Letizia; Dalcanale, Enrico; Ampollini, Luca; Careri, Maria.
Afiliación
  • Bianchi F; Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy. Electronic address: federica.bianchi@unipr.it.
  • Riboni N; Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy.
  • Carbognani P; Dipartimento di Medicina e Chirurgia, Via Gramsci 14, Università di Parma, 43121 Parma, Italy.
  • Gnetti L; Dipartimento di Medicina e Chirurgia, Via Gramsci 14, Università di Parma, 43121 Parma, Italy.
  • Dalcanale E; Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy.
  • Ampollini L; Dipartimento di Medicina e Chirurgia, Via Gramsci 14, Università di Parma, 43121 Parma, Italy.
  • Careri M; Dipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy.
J Pharm Biomed Anal ; 146: 329-333, 2017 Nov 30.
Article en En | MEDLINE | ID: mdl-28915496
Solid-phase microextraction and gas chromatography-mass spectrometry followed by multivariate data analysis were used to analyze lung tissues from both healthy and carcinogenic patients. A total of 78 volatile compounds belonging to different chemical classes were identified, seven of which were able to discriminate between the two groups. Discriminant analysis allowed to correctly classify 98.3% of the cases. By using the leave-one-method, 100% of the cross-validated samples belonging to the "tumor" group was correctly classified, whereas 2 cross-validated healthy samples out of 48 were erroneously allocated in the "tumor" group. Achieved results suggest the need of further investigation to assess the role of the seven identified compounds as lung cancer biomarkers in breath analysis, thus allowing the development of low-cost diagnostic devices.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Compuestos Orgánicos Volátiles / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Pharm Biomed Anal Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Compuestos Orgánicos Volátiles / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Pharm Biomed Anal Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido